PGEN
Precigen, Inc.
Biopharmaceutical company developing gene and cell therapies
CUSIP: 74017N105HealthcareUS1 holder
Total Value
$19.53M
Total Shares
13.75M
Net Share Change
+2.51M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Patient Capital Management
$19.53M13.75M shares
ADD+2.51M(+22.3%)